Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Scope Biosciences

Company Type: CRO

Main focus: Molecular diagnostics

Company stage: Actively providing services

Diseases: N/A

Genome-editing tool: Proprietary type III-CRISPR/Cas-platform

Funding stage: Series A

Location: Wageningen, Netherlands

Website: scopebio.com

Scope Bioscience is a Molecular Diagnostics CRO that uses CRISPR to develop kits for the detection of crop infectious species, particularly Tomato rugose fruit virus and Lettuce mosaic virus.

Tags

HashtagScope Biosciences

Company: Scope Biosciences
close
Search CRISPR Medicine